Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK1 | Q13464 | 1/20 | 0.38 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.32 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.31 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.31 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | LPL | P06858 | 3/20 | 0.30 |
| ▸ | LIPG | Q9Y5X9 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22748403 | 0.80 | LIPG (0.48) | ROCK1LPLLIPG | |
| SCHEMBL28689244 | 0.79 | LIPG (0.43) | ROCK1CXCR2LIPG | |
| SCHEMBL17525547 | 0.75 | HDAC1 (0.38) | TBXAS1LTB4RLTB4R2HDAC1HDAC8 | |
| SCHEMBL17165827 | 0.72 | ROCK1 (0.36) | ROCK1CXCR2LPLLIPG | |
| SCHEMBL31254711 | 0.72 | ROCK1 (0.36) | ROCK1CXCR2LPLLIPG | |
| SCHEMBL22575294 | 0.71 | AR (0.38) | ROCK1LPLLIPG | |
| SCHEMBL25241808 | 0.70 | ROCK1 (0.37) | ROCK1CXCR2LIPG | |
| SCHEMBL22527705 | 0.70 | ROCK1 (0.39) | ROCK1CXCR2 | |
| SCHEMBL29535058 | 0.70 | ROCK1 (0.39) | ROCK1CXCR2 | |
| SCHEMBL19194935 | 0.70 | LTB4R2 (0.41) | TBXAS1LTB4RLTB4R2HDAC1HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10727488-B2 | Redox mediators for metal-sulfur batteries | THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-07-28 | — | — | US | disclosed |
| US-20170222226-A1 | REDOX MEDIATORS FOR METAL-SULFUR BATTERIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2017-08-03 | — | — | US | disclosed |
| US-20170222226-A1 | REDOX MEDIATORS FOR METAL-SULFUR BATTERIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2017-08-03 | — | — | US | disclosed |
| WO-2016025467-A1 | REDOX MEDIATORS FOR METAL-SULFUR BATTERIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10727488-B2 | Redox mediators for metal-sulfur batteries | SQOR, NDUFS4, NDUFS3 | ROCK1 4667/4885TBXAS1 1276/4885LTB4R 866/4885 |
| US-20170222226-A1 | REDOX MEDIATORS FOR METAL-SULFUR BATTERIES | SQOR, NDUFS4, NDUFS3 | ROCK1 4667/4885TBXAS1 1276/4885LTB4R 866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.